Fangzheng Valve Group
920082
PILOT
831175
Kingsignal Technology
300252
Jiangsu Yitong High-tech
300211
Chengdu Qushui Science and Technology
301336
CN Stock MarketDetailed Quotes
300006 Chongqing Lummy Pharmaceutical
- 4.55
- -0.93-16.97%
Market Closed Dec 26 15:00 CST
4.80BMarket Cap252.78P/E (TTM)
5.10High4.38Low1.69MlotVolume5.03Open5.48Pre Close766.23MTurnover15.98%Turnover RatioLossP/E (Static)1.06BShares6.4352wk High2.34P/B4.80BFloat Cap2.0352wk Low6.58Limit Up1.06BShs Float21.82Historical High4.38Limit Down13.14%Amplitude2.03Historical Low--Dividend TTM4.54Avg Price755.53KlotAsk--Div YieldTTM100Lot Size878.30KlotBid
Chongqing Lummy Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.07%605.64M | -15.89%381.75M | -20.09%181.12M | 1.24%895.59M | -3.89%644.76M | 11.67%453.86M | 14.06%226.65M | -27.80%884.59M | -24.77%670.85M | -33.59%406.43M |
| Operating revenue | -6.07%605.64M | -15.89%381.75M | -20.09%181.12M | 1.24%895.59M | -3.89%644.76M | 11.67%453.86M | 14.06%226.65M | -27.80%884.59M | -24.77%670.85M | -33.59%406.43M |
| Other operating revenue | ---- | -23.61%9.25M | ---- | 11.59%21.34M | ---- | 33.67%12.1M | ---- | 30.91%19.13M | ---- | 37.02%9.05M |
| Total operating cost | -3.54%659.84M | -13.56%412.38M | -19.97%190.9M | -2.62%972.71M | -6.95%684.02M | 4.19%477.08M | 6.69%238.54M | -26.10%998.84M | -22.77%735.12M | -28.52%457.89M |
| Operating cost | 11.89%221.66M | -2.22%133.24M | -3.78%63.73M | 17.16%274.68M | 10.75%198.11M | 18.16%136.26M | 24.97%66.23M | -32.94%234.44M | -31.87%178.88M | -33.65%115.32M |
| Operating tax surcharges | -1.96%14.11M | -10.43%8.99M | -20.78%4.12M | 13.06%19.42M | 8.70%14.39M | 26.66%10.04M | 33.04%5.2M | -30.47%17.18M | -21.47%13.24M | -32.75%7.93M |
| Operating expense | -9.82%299.44M | -20.82%190.75M | -30.19%87.9M | -12.83%462M | -15.53%332.06M | 2.11%240.92M | 11.28%125.91M | -25.81%530.02M | -22.57%393.12M | -31.83%235.94M |
| Administration expense | -9.09%94.25M | -8.14%63.94M | 6.25%30.29M | 5.81%139.41M | 8.35%103.67M | 18.44%69.61M | -3.28%28.51M | -7.97%131.75M | 3.05%95.68M | -6.93%58.77M |
| Financial expense | 23.06%-13.99M | 23.63%-10.45M | -82.12%-5.43M | -570.34%-22.61M | -8,263.30%-18.18M | -3,883.33%-13.69M | -160,538.48%-2.98M | -75.36%4.81M | -101.09%-217.39K | -98.10%361.76K |
| -Interest expense (Financial expense) | -17.71%7.89M | -24.08%5.02M | -17.20%2.57M | -38.70%12.47M | -28.92%9.59M | -21.41%6.61M | -15.53%3.1M | -36.58%20.35M | -54.22%13.49M | -66.68%8.41M |
| -Interest Income (Financial expense) | 16.44%-22.59M | 20.97%-15.31M | -21.58%-7.96M | -167.94%-34.64M | -157.64%-27.04M | -187.88%-19.38M | -69.04%-6.54M | 4.43%-12.93M | -5.83%-10.49M | -0.11%-6.73M |
| Research and development | -17.79%44.37M | -23.65%25.91M | -34.31%10.3M | 23.76%99.81M | -0.83%53.97M | -14.24%33.93M | -34.81%15.68M | -19.51%80.65M | 4.83%54.42M | 48.18%39.57M |
| Credit Impairment Loss | 34.52%-5.41M | 66.97%-2.14M | -69.61%-2.64M | 90.77%-3.66M | 75.69%-8.26M | 74.66%-6.47M | 84.87%-1.56M | -69.09%-39.69M | -485.38%-33.97M | -311.48%-25.55M |
| Asset Impairment Loss | 21.55%-2.9M | 84.33%-427.82K | -143.97%-110.83K | -148.32%-5.04M | ---3.7M | ---2.73M | -904.12%-45.43K | 92.74%-2.03M | ---- | ---- |
| Other net revenue | -49.43%13.38M | 96.86%17.26M | 34.00%11.59M | 631.98%133.34M | 1,068.81%26.47M | 195.29%8.77M | 396.91%8.65M | -67.60%18.22M | -103.18%-2.73M | -113.56%-9.2M |
| Invest income | -2,552.76%-17.72M | -497.93%-9.58M | -715.50%-5.54M | 1,405.38%87.02M | 1.00%722.55K | -64.86%-1.6M | 43.82%-678.99K | -87.94%5.78M | -98.66%715.37K | -101.83%-971.5K |
| -Including: Investment income associates | -4,487.88%-18.71M | -551.16%-10.43M | -759.13%-5.83M | -727.07%-24.89M | 138.89%426.32K | -64.86%-1.6M | 43.82%-678.99K | 28.77%3.97M | 16.52%-1.1M | -9.41%-971.5K |
| Asset deal income | --65.5K | --10.02K | --8.01K | 79.31%446.09K | ---- | ---- | ---- | 951.16%248.78K | 9,236.79%213.4K | 88,162.46%213.4K |
| Other revenue | 4.36%39.35M | 50.17%29.39M | 81.79%19.87M | 1.24%54.58M | 24.41%37.71M | 14.41%19.57M | 27.43%10.93M | -9.84%53.91M | -19.85%30.31M | -17.00%17.1M |
| Operating profit | -218.91%-40.81M | 7.46%-13.38M | 155.88%1.81M | 158.55%56.23M | 80.90%-12.8M | 76.17%-14.45M | 88.36%-3.24M | -36.92%-96.04M | -360.53%-67M | -254.58%-60.65M |
| Add:Non operating Income | 38,068.80%30.36M | 896,834.60%30.19M | 8,050.72%4.27K | -98.44%328.3K | -99.62%79.54K | -79.37%3.37K | -90.19%52.41 | 8,495.77%21.02M | 9,135.13%21.02M | -92.85%16.31K |
| Less:Non operating expense | -99.52%252.24K | -99.75%128.77K | -33.56%43.7K | 23,453.47%52.96M | 59,176.88%52.28M | 80,943.50%52.04M | 100.07%65.77K | -99.38%224.85K | -83.39%88.2K | -87.67%64.22K |
| Total profit | 83.54%-10.7M | 125.09%16.68M | 153.58%1.77M | 104.78%3.59M | -41.08%-65M | -9.54%-66.49M | 88.13%-3.3M | 28.99%-75.25M | -281.29%-46.07M | -255.87%-60.7M |
| Less:Income tax cost | 568.55%4.82M | 329.86%7.89M | -59.65%1.74M | 1,213.90%13.61M | 23.30%-1.03M | 41.89%-3.43M | 266.22%4.31M | 3,878.49%1.04M | -115.88%-1.34M | -179.17%-5.91M |
| Net profit | 75.73%-15.52M | 113.94%8.79M | 100.41%31.38K | 86.87%-10.02M | -43.01%-63.97M | -15.08%-63.06M | 73.76%-7.61M | 27.99%-76.28M | -363.74%-44.73M | -274.05%-54.79M |
| Net profit from continuing operation | 75.75%-15.51M | 113.94%8.79M | 100.41%31.38K | 86.87%-10.02M | -43.01%-63.97M | -15.08%-63.06M | 73.76%-7.61M | 27.92%-76.28M | -363.74%-44.73M | -274.05%-54.79M |
| Net income from discontinuing operating | ---14.42K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---116.58 | ---- |
| Less:Minority Profit | 215.25%10.89M | 182.89%7.46M | 215.98%4.61M | 85.61%-1.09M | -28.51%-9.45M | -57.32%-9M | -53.51%-3.97M | -40.11%-7.58M | -144.39%-7.36M | -527.17%-5.72M |
| Net profit of parent company owners | 51.54%-26.42M | 102.46%1.33M | -25.90%-4.58M | 87.01%-8.93M | -45.86%-54.51M | -10.16%-54.06M | 86.24%-3.63M | 31.66%-68.71M | -287.15%-37.37M | -251.49%-49.07M |
| Earning per share | ||||||||||
| Basic earning per share | 51.55%-0.025 | 102.54%0.0013 | -26.47%-0.0043 | 86.94%-0.0085 | -45.76%-0.0516 | -10.11%-0.0512 | 86.40%-0.0034 | 35.54%-0.0651 | -272.68%-0.0354 | -234.01%-0.0465 |
| Diluted earning per share | 51.55%-0.025 | 102.54%0.0013 | -26.47%-0.0043 | 86.94%-0.0085 | -45.76%-0.0516 | -10.11%-0.0512 | 86.40%-0.0034 | 35.54%-0.0651 | -272.68%-0.0354 | -234.01%-0.0465 |
| Other composite income | -43.77M | |||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | ---43.77M | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | 75.73%-15.52M | 113.94%8.79M | 100.41%31.38K | 29.49%-53.79M | -43.01%-63.97M | -15.08%-63.06M | 73.76%-7.61M | 27.99%-76.28M | -363.74%-44.73M | -274.05%-54.79M |
| Total composite income of parent company owners | 51.54%-26.42M | 102.46%1.33M | -25.90%-4.58M | 23.30%-52.7M | -45.86%-54.51M | -10.16%-54.06M | 86.24%-3.63M | 31.66%-68.71M | -287.15%-37.37M | -251.49%-49.07M |
| Total composite income of minority owners | 215.25%10.89M | 182.89%7.46M | 215.98%4.61M | 85.61%-1.09M | -28.51%-9.45M | -57.32%-9M | -53.51%-3.97M | -40.11%-7.58M | -144.39%-7.36M | -527.17%-5.72M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
